Guide
L-tyrosine vs N-acetyl-L-tyrosine (NALT): what's actually different
N-acetyl-L-tyrosine (NALT) is a more soluble but poorly-converted form of L-tyrosine, distinct from NAC (N-acetylcysteine); the limited bioavailability research found NALT converts back to usable tyrosine poorly, and nearly all of tyrosine's cognitive-performance trials used the plain form.
L-tyrosine and N-acetyl-L-tyrosine (NALT) are related but different molecules — NALT is tyrosine with an acetyl group attached, mainly for water solubility — and the two aren't interchangeable milligram-for-milligram. The limited research that exists found NALT converts back to usable tyrosine poorly. This is also not the same thing as NAC (N-acetylcysteine), an unrelated compound made from a different amino acid.
What's the actual difference?
Free L-tyrosine is the amino acid the body uses directly to make dopamine, norepinephrine and epinephrine. N-acetyl-L-tyrosine (NALT) is tyrosine with an acetyl group chemically attached, which makes it more water-soluble than plain tyrosine — the reason some supplement makers prefer it in liquid or highly concentrated formulas. But that same acetyl group has to be removed before the body can use the tyrosine inside it, and the research on how well that conversion happens is not encouraging.
What the bioavailability research found
A 1989 human study infused 11 healthy volunteers with 5 g of N-acetyl-L-tyrosine over 4 hours. NALT levels in blood rose quickly, but tyrosine levels rose by only 25%, and 56% of the infused dose was excreted unchanged in urine within the 4 hours — the authors concluded NALT's usefulness as a tyrosine source in humans "was not apparent" under those conditions. A separate 1994 animal study in neonatal piglets compared N-acetyltyrosine against other aromatic amino acid sources fed through parenteral nutrition; N-acetyltyrosine performed worse on nitrogen utilization, and 65% of it was excreted unchanged in urine, confirming the same low-bioavailability pattern in a different species. Both studies used intravenous or parenteral delivery, not an oral capsule, so they don't directly measure what happens with a swallowed NALT supplement — but they're the closest bioavailability data that exists, and neither is encouraging for NALT as a tyrosine source.
Separately, essentially all of the human trials behind tyrosine's cognitive-performance findings — the noise-stress, sleep-loss, cold-and-altitude and military-training trials covered in L-tyrosine benefits: what the research does and doesn't show — used plain L-tyrosine, not NALT. None of that evidence transfers to a NALT-labeled product.
Not the same as NAC
N-acetyl-L-tyrosine (NALT) is easy to confuse with NAC (N-acetylcysteine) because of the similar-looking abbreviation, but they're unrelated compounds. NAC is made by acetylating the amino acid cysteine, not tyrosine, and is sold and researched for entirely different reasons. If a label says "NAC," it's not a tyrosine product at all.
Questions people ask
Is N-acetyl-L-tyrosine better than L-tyrosine?
The bioavailability research that exists points the other way: NALT converted back to usable tyrosine poorly in the studies reviewed above. "Better" usually means more soluble, not more effective — and effectiveness hasn't been tested for NALT the way it has for plain L-tyrosine.
Is NALT the same as NAC?
No. NALT is a form of tyrosine; NAC is a form of a different amino acid, cysteine. The two-letter overlap in the abbreviations is a naming coincidence, not a shared ingredient.
Related reading: what is L-tyrosine?, how to choose a good L-tyrosine, and L-tyrosine benefits: what the research does and doesn't show.
Sources
- N-acetyl-L-tyrosine and N-acetyl-L-cysteine as tyrosine and cysteine precursors during intravenous infusion in humans A 1989 human study found intravenously infused N-acetyl-L-tyrosine converted poorly into usable tyrosine — most of it was excreted unchanged in urine — leading the authors to question its usefulness as a tyrosine source; this was tested as an IV infusion, not an oral supplement.
- Aromatic amino acid metabolism of neonatal piglets receiving TPN: effect of tyrosine precursors A 1994 animal (piglet) study found N-acetyltyrosine had low bioavailability as a tyrosine source — 65% was excreted unchanged in urine — performing worse than other tyrosine-precursor forms tested.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.